Binding characteristics of N-acetylglucosamine-specific lectin of the isolated chicken hepatocytes: similarities to mammalian hepatic galactose/N-acetylgalactosamine-specific lectin.
Binding characteristics of N-acetylglucosamine- (GlcNAc) specific lectin on the chicken hepatocyte surface were probed by an inhibition assay using various sugars and glycosides as inhibitors. Results indicated that the binding area of the lectin is small, interacting only with GlcNAc residues whose 3- and 4-OH's are open. The combining site is probably of trough-type, since substitution with as large a group as monosaccharide is permitted on the C-6 side of GlcNAc, and on the C-1 side, the aglycon of GlcNAc can be very large (e.g., a glycoprotein). These binding characteristics are shared with the homologous mammalian lectin specific for galactose/N-acetylgalactosamine, suggesting that tertiary structure of the combining area of these two lectins is similar. This is understandable, since there is approximately 40% amino acid sequence identity in the carbohydrate recognition domain of these two lectins [Drickamer, K., Mannon, J. F., Binns, G., & Leung, J. O. (1984) J. Biol. Chem. 259, 770-778]. A series of glycosides, each containing two GlcNAc residues separated by different distances (from 0.8 to 4.7 nm), were synthesized. Inhibition assay with these and other cluster glycosides indicated that clustering of two or more GlcNAc residues increased the affinity toward the chicken lectin tremendously. Among the ligands containing two GlcNAc residues, the structure which allows a maximal inter-GlcNAc distance of 3.3 nm had the strongest affinity, its affinity increase over GlcNAc (monosaccharide) amounting to 100-fold. Longer distances slightly diminished the affinity, while shortening the distance caused substantial decrease in the affinity.(ABSTRACT TRUNCATED AT 250 WORDS)
Lee
R T
RT
Department of Biology, Johns Hopkins University, Baltimore, Maryland 21218.
Rice
K G
KG
Rao
N B
NB
Ichikawa
Y
Y
Barthel
T
T
Piskarev
V
V
Lee
Y C
YC
D000116:Acetylgalactosamine / Q000378:metabolism*; D000117:Acetylglucosamine / Q000378:metabolism*; D000818:Animals; D037263:Asialoglycoprotein Receptor; D001665:Binding Sites; D002241:Carbohydrates / Q000494:pharmacology; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D002645:Chickens; D005688:Galactosamine / Q000031:analogs & derivatives*; D005690:Galactose / Q000378:metabolism; D005944:Glucosamine / Q000031:analogs & derivatives*; D006020:Glycopeptides / Q000494:pharmacology; D037102:Lectins / Q000378:metabolism*; D008024:Ligands; D008099:Liver / Q000378:metabolism*; D015394:Molecular Structure; D011487:Protein Conformation; D011971:Receptors, Immunologic / Q000378:metabolism*; D034781:Receptors, N-Acetylglucosamine
D037263:Asialoglycoprotein Receptor; D002241:Carbohydrates; D006020:Glycopeptides; D037102:Lectins; D008024:Ligands; D011971:Receptors, Immunologic; D034781:Receptors, N-Acetylglucosamine; D005688:Galactosamine; D000116:Acetylgalactosamine; D005944:Glucosamine; D000117:Acetylglucosamine; D005690:Galactose